Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Protein Phosphoribosylation: Characterization of a novel protein modification

Award Number: R03DE034794
ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/16/2026
PERIOD OF PERFORMANCE END DATE: 03/31/2027

Group Awards By:

View Award Description

Protein Phosphoribosylation: Characterization of a novel protein modification - Abstract Herpesviruses are ubiquitous pathogens, and their infections are implicated in diverse diseases in human. Their infections can lead to life-threatening encephalitis under immune-deficient conditions. As obligate intracellular pathogens, viruses rely on cellular machinery to synthesize macromolecules for vial progeny production. Viruses are known to activate metabolic enzymes to fuel viral replication, however their functions beyond metabolism remain largely unchartered. By examining NAD+ metabolism in herpes simplex virus 1 (HSV- 1) infection, we discovered that the rate-limiting enzyme of the salvage NAD+ synthesis pathway, nicotinamide phosphoribosyltransferase (NAMPT), restricts HSV-1 lytic replication via dephosphoribosylating key structural proteins. Importantly, phosphoribosylation of these viral structural proteins facilitate their incorporation into virion progeny and subsequent infection. Among these structural proteins, VP22 is one of the most abundantly phosphoribosylated proteins of HSV-1. Protein phosphoribosylation is generally believed to be the degradation byproduct of ADP-ribosylation, a dynamic post-translational modification implicated in several diseased states, such as cancer, infection, chronic inflammation, and neurodegeneration. How phosphoribosylated proteins are generated from ADP-ribosylated proteins and its biological functions thereof have not been investigated in metazoans, particularly in the context of viral infection. For the first time, we have developed a system that enables the interrogation of the biochemistry and biological significance of protein phosphoribosylation in metazoans. Specifically, we have identified HSV-1 VP22 as a highly phosphoribosylated tegument protein and phosphoribosyl moieties of VP22 enhance its virion incorporation and subsequent infection of HSV-1 virions. This transition grant will characterize the biogenesis of phosphoribosylation of proteins using VP22 as a model substrate. Specifically, we will identify and characterize the enzyme(s) that catalyzes VP22 ADP-ribosylation (Aim 1) and subsequently process ADP-ribose to produce phosphoribose (Aim 2). In future, we will probe the roles of protein phosphoribosylation in HSV-1 infection in vivo. The reagents and system we develop here will constitute the toolkit for the study of protein post-translational modification to investigate viral protein phosphoribosylation in the subsequent project. Findings from this study will establish the first example of the biogenesis of protein phosphoribosylation in metazoan, pushing the boundary of our knowledge on protein post-translational modification in HSV-1 infection.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $157,001 )
2026	2026	CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE OF CASE WESTERN RESERVE UNIVERSITY	9500 EUCLID AVE.	CLEVELAND	OH	44195	CUYAHOGA	USA	Oral Diseases and Disorders Research	002	3	9/17/2026	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$157,000
2026	2026	BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE	1500 DUARTE RD	DUARTE	CA	91010	LOS ANGELES	USA	Oral Diseases and Disorders Research	000	2	3/5/2026	NON-COMPETING CONTINUATION	$178,000
2026	2026	BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE	1500 DUARTE RD	DUARTE	CA	91010	LOS ANGELES	USA	Oral Diseases and Disorders Research	001	2	9/15/2026	NON-COMPETING CONTINUATION	-$177,999
														Subtotal = $157,001

Issue Date FY: 2025 ( Subtotal = $178,000 )
2025	2025	BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE	1500 DUARTE RD	DUARTE	CA	91010	LOS ANGELES	USA	Oral Diseases and Disorders Research	000	1	3/24/2025	NEW	$178,000
														Subtotal = $178,000

Grand Total All Awards = $335,001

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Protein Phosphoribosylation: Characterization of a novel protein modification

Award Number: R03DE034794

ORGANIZATION: NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/16/2026

PERIOD OF PERFORMANCE END DATE: 03/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer